Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study explores lifestyle Program's impact on weight and heart health in women

NCT ID NCT07404150

Knowledge-focused Sponsor: Heather Conradson Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This 12-month study looks at how a lifestyle program—including group sessions and support from a nurse, dietitian, and kinesiologist—may help women aged 35-75 with obesity improve their weight, heart health, and body image. Some participants may also use GLP-1 weight-loss medication as part of their regular care. The study does not assign medication but observes outcomes over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women aged 35-75 years whose weight poses a CVD risk.

Ages

35 to 75 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Ability to provide informed consent before any study-related activities * Female * Age between 35 and 75 years * BMI ≥ 30 kg/m² with waist circumference ≥ 88 cm or BMI ≥ 27 kg/m² with obesity-related health conditions consistent with Edmonton Obesity Staging System Stage ≥ 1. * Willingness to engage in a 12-month interdisciplinary lifestyle program * Ability to attend group sessions (in person or virtually) and complete follow-up visits * Alberta resident with Alberta Health Care insurance * Sufficient proficiency in English to engage with group material and communications Exclusion Criteria: * Pregnant, breastfeeding, or planning to become pregnant during the study period * Diagnosis of type 1 diabetes * Life-limiting illness or severe medical condition where weight loss would not be clinically appropriate (e.g., advanced cancer, end-stage organ failure); clinical judgment will be used to assess suitability * Severe psychiatric illness or cognitive impairment that would interfere with participation in group sessions or study procedures * Current participation in another weight management or investigational study * Inability to comply with study procedures due to logistical, medical, or language barriers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity and cardiovascular risk

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Symphony of Health Connections

    Calgary, Alberta, T3G4L9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.